Published in Cas Lek Cesk on August 26, 1977
Occurrence of fetoprotein in patients with neoplasms and non-neoplastic diseases. Int J Cancer (1968) 1.53
Blood groups and neoplastic disease. Neoplasma (1965) 1.03
Cancer incidence and mortality in the Czech Republic. Klin Onkol (2010) 0.94
HLA and scleroderma. Tissue Antigens (1979) 0.86
Cancer incidence and mortality in the Czech Republic. Klin Onkol (2014) 0.86
HLA system and testicular germinative tumours. Oncology (1979) 0.86
The effect of anti A antibody on red cell organic phosphates and adenosine triphosphatase activity in vitro. Scand J Haematol (1968) 0.82
[Mixed germ cell tumours of the ovary in childhood and adolescence]. Cesk Patol (2004) 0.80
Progesterone binding to lymphocytes-cause for transient loss of HLA antigens in women? Folia Haematol Int Mag Klin Morphol Blutforsch (1980) 0.79
Non-relationship between the HLA system and the senile form of Alzheimer's disease. Arch Psychiatr Nervenkr (1970) (1983) 0.79
HLA and otosclerosis. Tissue Antigens (1982) 0.79
Loss of HLA antigens associated with hormonal state. Lancet (1976) 0.79
To the problem of immunotherapy of choriocarcinoma. Neoplasma (1965) 0.79
Estimating cancer incidence, prevalence, and the number of cancer patients treated with antitumor therapy in 2015 and 2020 - analysis of the Czech National Cancer Registry. Klin Onkol (2015) 0.78
[Effect of amifostine on reducing acute toxicity of megachemotherapy of tumors in children]. Cas Lek Cesk (2002) 0.78
Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients. Pediatr Hematol Oncol (2000) 0.77
[HLA-antigens in germ cell tumors of various sites]. Onkologie (1981) 0.75
Platelet antigens and chemotherapy. Neoplasma (1970) 0.75
[Immunological properties of blood platelets]. Vnitr Lek (1974) 0.75
[Reliable differentiation of A1B and A2B]. Klin Wochenschr (1970) 0.75
[Study of the weak B variant in a family (author's transl)]. Humangenetik (1973) 0.75
[Cytostatic therapy causing the loss of serological activity in thrombocytes]. Folia Haematol Int Mag Klin Morphol Blutforsch (1970) 0.75
[Unfavourable effects of leukocyte and thrombocyte antibodies in antithymocyte globulin (ATG) on the organism (author's transl)]. Z Immunitatsforsch Exp Klin Immunol (1974) 0.75
[Inhibition of antibody formation against serum proteins in the preparation of antilymphocyte serum (ALS) using lyophilized lymphocytes from the lymph]. Cesk Farm (1974) 0.75
[Occurrence of non-a red cells in rabbits after the simultaneous application of cyclophosphamide and methotrexate (author's transl)]. Z Immunitatsforsch Exp Klin Immunol (1973) 0.75
[Modifications of the H erythrocyte antigen in patients with leukemias. Studies on the occurrence of 2 blood cell populations]. Folia Haematol Int Mag Klin Morphol Blutforsch (1967) 0.75
[Attempt of classification of specific thrombocyte antigens. I. Employment of human antithrombocyte agglutination serums]. Z Immunitatsforsch Allerg Klin Immunol (1967) 0.75
[2-phase pronase test. A new rapid technic for determination of incomplete antibodies]. Cas Lek Cesk (1972) 0.75
[ Change in specifity and content of HL-A lymphocytotoxins in female sera during pregnancy and after delivery]. Cas Lek Cesk (1975) 0.75
[On the advantages and disadvantages of Eldon cards]. Vnitr Lek (1966) 0.75
[Choice of antigen for preparation of the anti-human antilymphocyte serum (ALS)]. Cesk Farm (1974) 0.75
[Immunological studies on the presence of thrombocyte antibodies in paroxysmal nocturnal hemoglobinuria]. Folia Haematol Int Mag Klin Morphol Blutforsch (1971) 0.75
Immunology of trophoblastic tumours. Neoplasma (1970) 0.75
[Serological and karyological changes in patients with blood diseases and malignant neoplasms]. Folia Haematol Int Mag Klin Morphol Blutforsch (1969) 0.75
[The effect of leukocyte and thrombocyte antibodies in anti-thymocyte globulin (ATG) on the organism]. Folia Haematol Int Mag Klin Morphol Blutforsch (1974) 0.75
[Further studies on the preparation and serological properties of "monovalent" rabbit immune antithrombocyte serum]. Z Immunitatsforsch Allerg Klin Immunol (1967) 0.75
[Incidence of thromboagglutinins in the antilymphocyte globulin (ALG)]. Cesk Farm (1974) 0.75
[Classification of specific thrombocyte antigens. V. Effect of enzymes on platelet antigens 1a, 2a, and 3a (Koa)]. Z Immunitatsforsch Allerg Klin Immunol (1970) 0.75
[Development of blood platelet antibodies following transfusions and during pregnancy]. Vnitr Lek (1971) 0.75
[Specifity of thrombocytic autoantibodies]. Folia Haematol Int Mag Klin Morphol Blutforsch (1973) 0.75
Antigenicity of blood platelets. Curr Top Microbiol Immunol (1969) 0.75
A weak, transient B-like antigen in the red cells of a patient with chronic leukaemia belonging to blood group A. Neoplasma (1965) 0.75
[Problems in the demonstration and typing of specific thrombocytic antibodies]. Vnitr Lek (1970) 0.75
[Serological character of the modifications of platelet antigens in malignant tumors]. Folia Haematol Int Mag Klin Morphol Blutforsch (1974) 0.75
[New aspects of the use of ficin in immunohematology]. Folia Haematol Int Mag Klin Morphol Blutforsch (1966) 0.75
[Unusual AB group in a blood donor (A1Bx mix)]. Cas Lek Cesk (1970) 0.75
[Dependence of lymphocytic antigen HL-A 12 expressivity on the presence of HL-A 2 (author's transl)]. Cas Lek Cesk (1975) 0.75
[Attempt at classification of specific thrombocye antigens. II. communication: the existence of antigens 1, 2 and 3(Koa)]. Z Immunitatsforsch Allerg Klin Immunol (1968) 0.75
[Survival time and occurrence of thrombocyte antibodies in thrombocytopenias]. Folia Haematol Int Mag Klin Morphol Blutforsch (1973) 0.75
[Proof of the existence of 2 erythrocyte populations, A2HPB and AmHPB in A2B subjects]. Z Immunitatsforsch Allerg Klin Immunol (1970) 0.75
[Serologic medifications of blood group antigens of erythrocytes in patients with malignant tumors]. Folia Haematol Int Mag Klin Morphol Blutforsch (1967) 0.75
[Unusual case of incidence of 2 populations of erythrocytes in a 75-year-old woman of the AB group]. Vnitr Lek (1973) 0.75
[Two erythrocyte populations, AB and weak A, in a patient with chronic leukemia]. Folia Haematol Int Mag Klin Morphol Blutforsch (1966) 0.75
[On the problem of pretransfusion examination in extracorporeal circulation]. Vnitr Lek (1966) 0.75
[Attempt at classifying specific thrombocyte antigens. 7. The difference between the 2a-antigen and fibrinogen and thrombin]. Z Immunitatsforsch Exp Klin Immunol (1970) 0.75
[n the problem of the cause of non-specific positive results of the 2-phase serum trypsin test]. Z Immunitatsforsch Allerg Klin Immunol (1965) 0.75
[Antibody production in rabbits by oral immunization with human blood platelets]. Z Immunitatsforsch Allerg Klin Immunol (1970) 0.75
An attempt to eliminate platelet antibodies from antilymphocyte serum (ALS) by absorption with unwashed human erythrocytes. Folia Biol (Praha) (1975) 0.75
Frequency and serological character of changes of group ABH-antigens in blood diseases and malignant tumours. Neoplasma (1967) 0.75
[Determination of the AHP-receptor on human thrombocytes]. Z Immunitatsforsch Allerg Klin Immunol (1969) 0.75
[Further studies on the reason for the prozone-phenomenon in Pirofsky's bromelin test]. Z Immunitatsforsch Allerg Klin Immunol (1967) 0.75
[Attempt at classifying specific thrombocyte antigens. 9. Presence of free platelet antigens in human plasma]. Z Immunitatsforsch Exp Klin Immunol (1971) 0.75
Immunological investigation of choriocarcinomas. 1. Incidence of platelet antibodies. Neoplasma (1967) 0.75
[Further experiences with the bromelin VEB Arzneimittelwork Dresden]. Folia Haematol Int Mag Klin Morphol Blutforsch (1968) 0.75
[Atypical A1B blood group in a healthy blood donor]. Haematologia (Budap) (1971) 0.75
[High-titre anti-A1 serum agglutinins in a female patient with weak A-variant (author's transl)]. Cas Lek Cesk (1974) 0.75
[A new modification of the trypsin test: 2-phase serum-trypsin test]. Cas Lek Cesk (1965) 0.75
[Typing of thrombocytic antigens with the aid of rabbit immune antithrombocytic sera]. Z Immunitatsforsch Allerg Klin Immunol (1965) 0.75
[Loss of specific platelet agglutinability in rabbits after the application of cyclophosphamide and methotrexate]. Z Immunitatsforsch Exp Klin Immunol (1971) 0.75
[Immunologic studies on the chorionepithelioma. II. Serologic relationships between placental and platelet antigens]. Z Immunitatsforsch Allerg Klin Immunol (1968) 0.75
[The occurrence of erythrocyte populations AHP and non-AHP in blood disease patients]. Dtsch Gesundheitsw (1971) 0.75
[Serologic modifications of the ABH and D(Rho)-blood group antigens in erythrocytes of patients with blood diseases (excepting leukemias)]. Folia Haematol Int Mag Klin Morphol Blutforsch (1969) 0.75
[Classification of specific platelet antigens. VI. Conditions for the reliability of the phenol test]. Z Immunitatsforsch Allerg Klin Immunol (1970) 0.75
[Attempt at classification of specific thrombocyte antigens. IV. Various effects of warming and chemicals on antigens la and 3a (Koa) and on factor 2a]. Z Immunitatsforsch Allerg Klin Immunol (1969) 0.75
[Considerations on HL-A antigens and their isolation]. Folia Haematol Int Mag Klin Morphol Blutforsch (1974) 0.75
[Immunologic studies in oligophrenics (author's transl)]. Cas Lek Cesk (1974) 0.75
A simultaneous modification of A agglutinogen of erythrocytes and loss of specific platelet antigens in a patient with gall bladder carcinoma. Neoplasma (1969) 0.75
Thrombocyte A-antigen deficiency in malignant disease. Neoplasma (1968) 0.75
[Anti-Jka antibody in a patient with acute leukemia]. Cas Lek Cesk (1966) 0.75
[Attempt at a classification of the specific platelet antigens. 3. Demonstration of the allele antigen lb in the 1 system]. Z Immunitatsforsch Allerg Klin Immunol (1969) 0.75
[Serological modifications of blood group antigens from human blood cells in malignant diseases. Causes, serological character and meaning]. Folia Haematol Int Mag Klin Morphol Blutforsch (1970) 0.75
[Attempt at the creation of serologic changes in the blood group antigens in vitro and in vivo]. Blut (1968) 0.75
[Attempt at classifying specific blood platelet antigens. 8. Identification of another specific blood platelet antigen 4a]. Z Immunitatsforsch Exp Klin Immunol (1971) 0.75
[Implementation of the microcytotoxic test for the determination of HL-A antigens]. Vnitr Lek (1974) 0.75
[Cryoprecipitates. 4. Antigenic properties of cryoprecipitates]. Folia Haematol Int Mag Klin Morphol Blutforsch (1974) 0.75
[Effect of room temperature on the preparation of blood-platelet concentrates and on the productivity of AHG in cryoproteins]. Vnitr Lek (1974) 0.75
[Anti-A HP, a group specificity of snail origin]. Vnitr Lek (1971) 0.75
[Micromethod for thromboagglutinins and erythrocyte antigens assay (author's transl)]. Cas Lek Cesk (1974) 0.75
[Attempt at classifying specific thrombocyte antigens 11th communication: the evidence of the platelet antigen 5a (author's transl)]. Z Immunitatsforsch Exp Klin Immunol (1973) 0.75
Some cases of leukaemia with modifications of the D(Rho)-receptor. Neoplasma (1967) 0.75
[Specificity and effectiveness of HL-A sera from the firms Behringwerke and Biotest-Serum-Institut]. Cesk Farm (1975) 0.75
[Study of anti-T-agglutinins in active and inactivated human sera (author's transl)]. Z Immunitatsforsch Exp Klin Immunol (1975) 0.75
[Evidence of an agglutinating factor against the red cells modified by pronase in human sera (author's transl)]. Z Immunitatsforsch Exp Klin Immunol (1973) 0.75
[Studies on changes in lymphocyte HL-A antigens during the course of malignant diseases]. Folia Haematol Int Mag Klin Morphol Blutforsch (1975) 0.75
[Influence of temperature changes and storing at 4 degrees c on HL-A lymphocytotoxins in the human sera (author's transl)]. Cas Lek Cesk (1975) 0.75
[On the problem of the use of enzyme mixtures in immunohematology]. Vnitr Lek (1968) 0.75